This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Imperva (IMPV) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Imperva (IMPV) delivered earnings and revenue surprises of 138.89% and 2.69%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Lumentum (LITE) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Lumentum Holdings (LITE) first-quarter fiscal 2019 results are expected to benefit from robust ROADMs demand but decline in high margin laser business remains an overhang
Attunity (ATTU) Set to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Attunity's (ATTU) third-quarter 2018 results are likely to benefit from strong demand for term licenses and portfolio strength.
Imperva (IMPV) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Imperva, Inc. (IMPV).
Imperva (IMPV) Expands Portfolio With Acquisition of Prevoty
by Zacks Equity Research
Imperva (IMPV) aims to make strategic acquisitions to broaden its technology and offerings, allowing organizations to protect applications and data on premise, in both cloud and hybrid environment.
Forget Tech Woes: Buy These Cybersecurity Stocks & ETFs
by Sanghamitra Saha
Inside the strong fundamentals in cybersecurity stocks and ETFs.
Qualys (QLYS) and Imperva (IMPV) Are Aggressive Growth Rank Buys
by Brian Bolan
A look at two cyber security stocks for your aggressive growth stock radar.
Proofpoint to Buy Weblife, Extend Protection Capabilities
by Zacks Equity Research
Proofpoint (PFPT) aimed at extending advanced threat-protection capabilities into personal email with Weblife.io buyout.
FireEye (FEYE) Posts Narrower Q3 Loss, Down on Weak '17 View
by Zacks Equity Research
FireEye (FEYE) plunged yesterday despite reporting splendid Q3 results as its Q4 outlook fell short of analysts' expectations.
Check Point (CHKP) Q3 Earnings Top, Q4 View Soft, Stock Down
by Zacks Equity Research
Despite posting a solid Q3, Check Point (CHKP) fell yesterday, after it hinted that Q4 revenues may be hit by significant changes in the U.S. sales force that may take time to reach full potential.
The Zacks Analyst Blog Highlights: Equifax, Imperva, Leidos Holdings and Varonis Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Equifax, Imperva, Leidos Holdings and Varonis Systems
New Strong Buy Stocks for August 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CyberArk (CYBR) Q2 Earnings Decline on Sluggish Sales Growth
by Zacks Equity Research
CyberArk's (CYBR) second-quarter 2017 earnings declined year-over-year due to lower-than-expected sales growth and elevated operating expenses.
Imperva (IMPV) and Twilio (TWLO) are Aggressive Growth Rank Buys
by Brian Bolan
A look at two stocks with strong growth stock profiles.
Bet on Momentum with These ETFs & Stocks
by Sweta Killa
Dow Jones crossed the another milestone of 22,000 for the first time in yesterday???s trading session and the S&P 500 is less than 1% shy of its major threshold of 2,500.
FireEye (FEYE) Soars on Narrower Q2 Loss & Upbeat 2017 View
by Zacks Equity Research
FireEye's (FEYE) turnaround efforts such as product refreshes, acquisitions and cost optimization seem to be paying off, as indicated by the company's splendid second-quarter 2017 results.
Zacks Investment Ideas feature highlights: Imperva, Cyberark Software, Proofpoint, Rapid7 and VASCO Data Security
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Imperva, Cyberark Software, Proofpoint, Rapid7 and VASCO Data Security
Best Cyber Security Stocks To Buy Now
by Brian Bolan
A recent ransomware attack has caused several stocks to run higher, but which ones should you target?
Zacks Investment Ideas feature highlights: Imperva, FireEye, CyberArk Software and Rapid7
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Imperva, FireEye, CyberArk Software and Rapid7
Software Security Stocks That Beat And Guide Higher
by Brian Bolan
IMPV posted some really solid numbers last night and that has lifted the whole sector, but I believe the best beat is yet to come and I reveal who it will come from.
Check Point (CHKP) Q1 Earnings & Revenues Beat, Guides Well
by Zacks Equity Research
Check Point Software Technologies Ltd. (CHKP) reported strong results for first-quarter 2017, wherein revenues and earnings came at the higher end of the company's expectations and surpassed the respective Zacks Consensus Estimate.
Proofpoint (PFPT) Q1 Loss Narrows, 2017 Guidance Revised Up
by Zacks Equity Research
Shares of Proofpoint Inc. (PFPT) went up sharply in the after-hour trade following the company reported better-than-expected first-quarter top-line results and raised its outlook for 2017.
TiVo Corp (TIVO) Q4 Earnings Fall Y/Y, Revenues Increase
by Zacks Equity Research
TiVo Corporation (TIVO) reported decent fourth-quarter 2016 results, wherein its revenues improved year over year but earnings declined.
Symantec Closes LifeLock Acquisition, Boosts Digital Safety
by Zacks Equity Research
Cybersecurity firm Symantec Corporation (SYMC) recently completed the acquisition of Arizona-based LifeLock Inc. in less than three months from signing the deal.
Bolan's Blowouts looks at Imperva (IMPV) and Vince Holdings (VNCE)
by Brian Bolan
IMPV provided the big beat and the air is coming out of the VNCE balloon.